{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:44Z","timestamp":1790742044893,"version":"4.1.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00847","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T01:07:52Z","timestamp":1589936872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Toshifumi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","article-title":"Autoinflammatory keratinization disease","volume":"140","author":"Akiyama","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.jaci.2018.01.010","article-title":"Hidradenitis suppurativa as an autoinflammatory keratinization disease","volume":"141","author":"De Vita","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/bjd.18445","article-title":"A novel NCSTN missense mutation in the signal peptide domain causes hideradenitis suppurativa, which has features characteristic of an autoinflammatory keratinization disease","volume":"182","author":"Takeichi","year":"2019","journal-title":"Br J Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1111\/1346-8138.14666","article-title":"Familial or sporadic porokeratosis as an autoinflammatory keratinization disease","volume":"46","author":"Takeichi","year":"2019","journal-title":"J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16603","article-title":"Profound consequences of hidradenitis suppurativa: a review","author":"Matusiak","year":"2018","journal-title":"Br J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/bjd.17928","article-title":"Even mild hidradenitis suppurativa impairs quality of life","volume":"181","author":"Senthilnathan","year":"2019","journal-title":"Br J Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/bjd.14975","article-title":"Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study","volume":"176","author":"Janse","year":"2017","journal-title":"Br J Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case\u2013control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: epidemiology and scope of the problem","volume":"73","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based clinical practice research datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/bjd.14038","article-title":"Diagnostic delay in hidradenitis suppurativa is a global problem","volume":"173","author":"Saunte","year":"2015","journal-title":"Br J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"\u03b3-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1365-2133.1990.tb06264.x","article-title":"Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands","volume":"122","author":"Yu","year":"1990","journal-title":"Br J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","article-title":"Histology of hidradenitis suppurativa","volume":"34","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/jid.2012.162","article-title":"Mutations in the \u03b3-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of Hidradenitis Suppurativa (acne inversa)","volume":"132","author":"Pink","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jmg.22.5.367","article-title":"A family study of hidradenitis suppurativa","volume":"22","author":"Fitzsimmons","year":"1985","journal-title":"J Med Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","article-title":"The clinical genetics of hidradenitis suppurativa revisited","volume":"142","author":"Von Der Werth","year":"2000","journal-title":"Br J Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma- secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/jid.2011.62","article-title":"Confirmation by exome sequencing of the pathogenic role of NCSTN mutations in acne inversa (hidradenitis suppurativa)","volume":"131","author":"Liu","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2133.2012.11174.x","article-title":"A novel splice site mutation in NCSTN underlies a Japanese family with Hidradenitis Suppurativa","volume":"168","author":"Nomura","year":"2013","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/jid.2011.42","article-title":"PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa)","volume":"131","author":"Pink","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/jid.2012.23","article-title":"Nicastrin mutations in French families with Hidradenitis Suppurativa","volume":"132","author":"Miskinyte","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamadermatol.2014.5306","article-title":"Gamma-secretase mutation in an African American family with Hidradenitis Suppurativa","volume":"151","author":"Chen","year":"2015","journal-title":"JAMA Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jdermsci.2014.01.013","article-title":"A novel NCSTN mutation alone may be insufficient for the development of familial Hidradenitis Suppurativa","volume":"74","author":"Nomura","year":"2014","journal-title":"J Dermatol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/bjd.14482","article-title":"Genetic analysis of NCSTN for potential association with hidradenitis suppurativa in familial and nonfamilial patients","volume":"175","author":"Liu","year":"2016","journal-title":"Br J Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjd.17695","article-title":"Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa","volume":"181","author":"Frew","year":"2019","journal-title":"Br J Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1474-4422(09)70332-1","article-title":"Gamma-secretases: from cell biology to therapeutic strategies","volume":"9","author":"Bergmans","year":"2010","journal-title":"Lancet Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jid.2017.09.051","article-title":"Hidradenitis Suppurativa-like lesions associated with pharmacologic inhibition of gamma-secretase","volume":"138","author":"O'Sullivan Coyne","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.devcel.2004.09.014","article-title":"Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis","volume":"7","author":"Pan","year":"2004","journal-title":"Dev Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"32264","DOI":"10.1074\/jbc.M703649200","article-title":"Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/bjd.16264","article-title":"Novel POFUT1 mutation associated with hidradenitis suppurativa-Dowling-Degos disease firm up a role for Notch signalling in the pathogenesis of this disorder","volume":"178","author":"Gonz\u00e1lez-Villanueva","year":"2018","journal-title":"Br J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/hmg\/ddy414","article-title":"Analysis of hidradenitis suppurativa-linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages","volume":"28","author":"Li","year":"2019","journal-title":"Hum Mol Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1172\/JCI90667","article-title":"Mutations in gamma-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa","volume":"127","author":"Ralser","year":"2017","journal-title":"J Clin Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.jid.2017.05.021","article-title":"PSENEN mutation carriers with co-manifestation of acne inversa (AI) and dowling-degos disease (DDD): is AI or DDD the subphenotype?","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.16000","article-title":"A phenotype combining hidradenitis suppurativa with Dowling-Degos disease caused by a founder mutation in PSENEN","volume":"178","author":"Pavlovsky","year":"2018","journal-title":"Br J Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.15851","article-title":"Follicular occlusion tetrad in a male patient with pachyonychia congenita: clinical and genetic analysis","volume":"33","author":"Musumeci","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1468-3083.2008.02691.x","article-title":"Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy","volume":"22","author":"Pedraz","year":"2008","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmed.2017.00016","article-title":"Generalized comedones, acne, and hidradenitis suppurativa in a patient with an FGFR2 missense mutation","volume":"4","author":"Higgins","year":"2017","journal-title":"Front Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2003.12.042","article-title":"A novel connexin 26 gene mutation associated with features of the keratitis- ichthyosis-deafness syndrome and the follicular occlusion triad","volume":"51","author":"Montgomery","year":"2004","journal-title":"J Am Acad Dermatol."},{"key":"B44","first-page":"347","article-title":"Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad","volume":"15","author":"Maintz","year":"2005","journal-title":"Eur J Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1525-1470.2011.01425.x","article-title":"Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings","volume":"29","author":"Lazic","year":"2012","journal-title":"Pediatr Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/bjd.14383","article-title":"PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome","volume":"175","author":"Calderon-Castrat","year":"2016","journal-title":"Br J Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ijd.13503","article-title":"Familial Mediterranean fever patients with hidradenitis suppurativa","volume":"56","author":"Vural","year":"2017","journal-title":"Int J Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitissuppurativa: a case-control study","volume":"180","author":"Vural","year":"2019","journal-title":"Br J Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jdcr.2019.06.035","article-title":"Hidradenitis suppurativa and Mediterranean fever gene mutations","volume":"5","author":"Ilgen","year":"2019","journal-title":"JAAD Case Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fimmu.2019.00892","article-title":"An integrated approach to unravel hidradenitis suppurativa etiopathogenesis","volume":"10","author":"Tricarico","year":"2019","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Witte-H\u00e4ndel","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00011-017-1074-y","article-title":"The critical role of macrophages in the pathogenesis of hidradenitis suppurativa","volume":"66","author":"Shah","year":"2017","journal-title":"Inflamm Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis Suppurativa is characterized by dysregulation of the Th17:treg cell axis, which is corrected by anti-TNF therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/bjd.16561","article-title":"T helper 17 cell\/regulatory T-cell imbalance in hidradenitis suppurativa\/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities","volume":"179","author":"Melnik","year":"2018","journal-title":"Br J Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coph.2019.04.006","article-title":"Pharmacological development in hidradenitis suppurativa","volume":"46","author":"Matusiak","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","article-title":"Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3-year results of a phase 3 open-label extension study","volume":"80","author":"Zouboulis","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjd.17822","article-title":"Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitissuppurativa","volume":"181","author":"Prussick","year":"2019","journal-title":"Br J Dermatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/bjd.13668","article-title":"First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome","volume":"173","author":"Duchatelet","year":"2015","journal-title":"Br J Dermatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T01:07:55Z","timestamp":1589936875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2020.00847"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00847","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738107918.793580802","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"article-number":"847"}}